{"id":"W4307911011","doi":"10.1016/s0959-8049(22)00972-8","title":"Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Melanoma; Cancer research; Vemurafenib; Medicine; Mutant; Targeted therapy; Cancer; MEK inhibitor; Biology; MAPK/ERK pathway; Gene; Internal medicine; Signal transduction; Genetics; Metastatic melanoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062682,0.0004325729,0.0004831287,0.0007028296,0.0001808052,0.001030555,0.0004704444,0.0005358265,0.00106081],"category_scores_gemma":[0.000373209,0.0002381438,0.0003910927,0.0003994409,0.0003720859,0.0008971355,0.000261949,0.0007706631,0.0002157206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006073366,"about_ca_system_score_gemma":0.0004207328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004652749,"about_ca_topic_score_gemma":0.0008275566,"domain_scores_codex":[0.9998498,0.00002978123,0.00001057348,0.00002629999,0.00003766387,0.00004588265],"domain_scores_gemma":[0.9998901,0.0000241341,0.000040045,0.00001277169,0.0000165582,0.00001642709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001558171,0.0003373313,0.02750139,0.0005326536,0.0001647584,0.0006457001,0.0002079321,0.001960369,0.8530746,0.005823609,0.001236647,0.1069569],"study_design_scores_gemma":[0.0004454847,0.00468445,0.2092551,0.0001968627,0.0007885422,0.01256506,0.001208231,0.01893833,0.6756338,0.0200848,0.05606996,0.0001294165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422184,0.04295908,0.007458648,0.001922772,0.0000627658,0.00009560616,0.000472948,0.0001364663,0.00467337],"genre_scores_gemma":[0.9827113,0.01350359,0.00207146,0.0002657826,0.0000529776,0.00004745523,0.0002812454,0.00001400278,0.001052271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00106081,"threshold_uncertainty_score":0.004406571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02404520859833804,"score_gpt":0.236548604791952,"score_spread":0.212503396193614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}